107 related articles for article (PubMed ID: 19357605)
1. Psychotic mania induced by the withdrawal of pegylated interferon and ribavirin treatment.
Ganeshalingam Y; Suleman S; Francis M
Br J Hosp Med (Lond); 2009 Apr; 70(4):233. PubMed ID: 19357605
[No Abstract] [Full Text] [Related]
2. Case of mania induced by withdrawal of interferon-alpha in a patient affected by bipolar disorder.
Rossi A; Renzetti D; D'Albenzio L; Gianfelice D; Kalyvoka A; Rinaldi O
Psychiatry Clin Neurosci; 2002 Dec; 56(6):647-8. PubMed ID: 12485309
[No Abstract] [Full Text] [Related]
3. Interferon for hepatitis C patients with psychiatric disorders.
Asnis GM; De La Garza R; Rego SA; Henderson MA; Reinus JF
Am J Psychiatry; 2004 Dec; 161(12):2332; author reply 2332-4. PubMed ID: 15569920
[No Abstract] [Full Text] [Related]
4. Peginterferon- and ribavirin-induced bipolar episode successfully treated with lamotrigine without discontinuation of antiviral therapy.
Navinés R; Castellví P; Solà R; Martín-Santos R
Gen Hosp Psychiatry; 2008; 30(4):387-9. PubMed ID: 18585548
[No Abstract] [Full Text] [Related]
5. Mania during treatment of chronic hepatitis C with pegylated interferon and ribavirin.
Onyike CU; Bonner JO; Lyketsos CG; Treisman GJ
Am J Psychiatry; 2004 Mar; 161(3):429-35. PubMed ID: 14992966
[No Abstract] [Full Text] [Related]
6. Pegylated interferon and ribavirin therapy for hepatitis C causing cataract.
Ku JY; Sharma A
Clin Exp Ophthalmol; 2009 Sep; 37(7):743-5. PubMed ID: 19788675
[No Abstract] [Full Text] [Related]
7. Interferon for hepatitis C patients with psychiatric disorders.
Rifai MA; Bozorg B; Rosenstein DL
Am J Psychiatry; 2004 Dec; 161(12):2331-2; author reply 2332-4. PubMed ID: 15569919
[No Abstract] [Full Text] [Related]
8. Interferon-induced mania.
Malik AR; Ravasia S
Can J Psychiatry; 2004 Dec; 49(12):867-8. PubMed ID: 15679218
[No Abstract] [Full Text] [Related]
9. Reversible decompensated liver disease as a possible complication of pegylated-interferon alfa 2b and ribavirin for recurrent hepatitis C.
Mukherjee S
J Gastroenterol Hepatol; 2004 Jun; 19(6):723-4. PubMed ID: 15151639
[No Abstract] [Full Text] [Related]
10. Incidence of psychiatric side effects during pegylated interferon- alpha retreatment in nonresponder hepatitis C virus-infected patients.
Quarantini LC; Bressan RA; Galvão A; Batista-Neves S; Paraná R; Miranda-Scippa A
Liver Int; 2007 Oct; 27(8):1098-102. PubMed ID: 17845538
[TBL] [Abstract][Full Text] [Related]
11. Rosacea fulminans associated with pegylated interferon alpha-2B and ribavirin therapy.
Jensen SL; Holmes R
J Drugs Dermatol; 2003 Oct; 2(5):554-6. PubMed ID: 14558405
[TBL] [Abstract][Full Text] [Related]
12. Adult respiratory distress syndrome after treatment with pegylated interferon alpha-2a and ribavirin.
Vartany E; Caldwell CA; Trow TK
Heart Lung; 2008; 37(2):153-6. PubMed ID: 18371508
[TBL] [Abstract][Full Text] [Related]
13. Lingual hyperpigmentation with pegylated interferon and ribavirin therapy in patients with chronic hepatitis C.
Sood A; Midha V; Bansal M; Goyal A; Sharma N
Indian J Gastroenterol; 2006; 25(6):324. PubMed ID: 17264447
[No Abstract] [Full Text] [Related]
14. [Severe local cutaneous necrosis during treatment with interferon-alpha and ribavirin for chronic viral hepatitis C].
de Ledinghen V; Brudieux E; Beylot-Barry M; Belleannee G; Doutre MS; Couzigou P
Gastroenterol Clin Biol; 1997; 21(6-7):523-4. PubMed ID: 9295983
[No Abstract] [Full Text] [Related]
15. Cryptosporidiosis in a patient on PEG-interferon and ribavirin for recurrent hepatitis C after living donor liver transplantation.
Manz M; Steuerwald M
Transpl Infect Dis; 2007 Mar; 9(1):60-1. PubMed ID: 17313476
[TBL] [Abstract][Full Text] [Related]
16. [Healing hepatitis C infections. Pegylated interferon alfa-2a opens new perspectives].
MMW Fortschr Med; 2003 Jun; 145(26):52-3. PubMed ID: 12916339
[No Abstract] [Full Text] [Related]
17. [Hepatitis C therapy is not pleasant. Patients must be prepared!].
MMW Fortschr Med; 2003 Jan; 145(3-4):57. PubMed ID: 12619237
[No Abstract] [Full Text] [Related]
18. Side effects. Bone problems may occur with hepatitis treatment.
TreatmentUpdate; 2000 Sep; 12(6):7-8. PubMed ID: 12132465
[No Abstract] [Full Text] [Related]
19. Crohn's disease onset in an HIV/hepatitis C virus co-infected woman taking pegylated interferon alpha-2b plus ribavirin.
Bongiovanni M; Ranieri R; Ferrero S; Casanova F; Monforte Ad
AIDS; 2006 Oct; 20(15):1989-90. PubMed ID: 16988527
[No Abstract] [Full Text] [Related]
20. Nonischemic cardiomyopathy related to pegylated interferon and ribavirin.
Choy-Shan A; Berezovskaya S; Zinn A; Sedlis SP; Bini EJ
Eur J Gastroenterol Hepatol; 2009 Dec; 21(12):1438-40. PubMed ID: 19907230
[No Abstract] [Full Text] [Related]
[Next] [New Search]
